Showing results (11-20 of 46) with videos related to
Sort By:
Pageof 5
The Journal of Infectious Diseases|August 27, 2002
Impact of human immunodeficiency virus type 1 subtypes on virologic response and emergence of drug resistance among children in the Paediatric European Network for Treatment of AIDS (PENTA) 5 trialDeenan Pillay, A Sarah Walker, Diana M Gibb, et al.AIDS (London, England)|February 9, 2012
Increased levels of CD4 T-cell activation in individuals with CXCR4 using viruses in primary HIV-1 infectionElizabeth Hamlyn, Stephen Hickling, Kholoud Porter, et al.Plos One|March 17, 2011
Investigation into the presence of and serological response to XMRV in CFS patientsOtto Erlwein, Mark J Robinson, Steve Kaye, et al.HIV Clinical Trials|August 2, 2012
Alterations in cerebrospinal fluid chemokines are associated with maraviroc exposure and in vivo metabolites measurable by magnetic resonance spectroscopyJaime H Vera, Lucy J Garvey, Joanna M Allsop, et al.The Journal of Infectious Diseases|April 22, 2008
Virological and immunological correlates of mother-to-child transmission of cytomegalovirus in The GambiaSteve Kaye, David Miles, Pierre Antoine, et al.Journal of Virology|March 15, 2019
Kinetics of Early Innate Immune Activation during HIV-1 Infection of Humanized MiceJessica Katy Skelton, Ana Maria Ortega-Prieto, Steve Kaye, et al.AIDS (London, England)|January 25, 2002
The effects of antiretroviral therapy on HIV-1 RNA loads in seminal plasma in HIV-positive patients with and without urethritisS Tariq Sadiq, Stephen Taylor, Steve Kaye, et al.Retrovirology|January 22, 2013
Restriction of V3 region sequence divergence in the HIV-1 envelope gene during antiretroviral treatment in a cohort of recent seroconvertersAstrid Gall, Steve Kaye, Stéphane Hué, et al.Journal of Clinical Microbiology|April 19, 2013
Results of external quality assessment for proviral DNA testing of HIV tropism in the Maraviroc Switch collaborative studyElise Tu, Luke C Swenson, Sally Land, et al.The Journal of Antimicrobial Chemotherapy|February 14, 2014
Rilpivirine exposure in plasma and sanctuary site compartments after switching from nevirapine-containing combined antiretroviral therapyBorja Mora-Peris, Victoria Watson, Jaime H Vera, et al.Pageof 5